Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)

Abstract

We investigated the impact of neutralizing antibodies (NAbs) on CD4 T-cell count and viral load in a cohort of HAART recipients who underwent extended structured treatment interruption

    Similar works